Valentina Saia

Valentina Saia

Auto-generated profile, based on publicly available information

Valentina Saia

Department of Neurology Santa Corona Hospital Pietra Ligure Italy

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2012 in International Journal of Stroke
Verified
Journal Article
Closed access
ABAlessandra Del Bene
Alessandra Del Bene
VPVanessa Palumbo
Vanessa Palumbo
MLMaria Lamassa
Maria Lamassa
VSValentina Saia
Valentina Saia
BPBenedetta Piccardi
Benedetta Piccardi
DIDomenico Inzitari
Domenico Inzitari

25 September 2008 in Experimental Brain Research
Verified
Journal Article
Closed access
PDF file
Filippo BrighinaFilippo Brighina
Filippo Brighina
MRM. Romano
M. Romano
Giuseppe GigliaGiuseppe Giglia
Giuseppe Giglia
VSV. Saia
V. Saia
APA. Puma
A. Puma
BFB. Fierro
B. Fierro

27 July 2009 in Neuroepidemiology
Verified
Journal Article
Closed access
PDF file
VTValeria Terruso
Valeria Terruso
MDMarco D'Amelio
Marco D'Amelio
NBNorma Di Benedetto
Norma Di Benedetto
ILInnocenzo Lupo
Innocenzo Lupo
VSValentina Saia
Valentina Saia
GSGiovanni Savettieri
Giovanni Savettieri
Background: Frequency and associated risk factors for hemorrhagic transformation (HT), a worrying complication of ischemic stroke (IS), are not clearly defined. Our aim was to estimate the overall frequency and risk factors for HT in a hospital-based population. Methods: A retrospective review of medical records of patients discharged from our department during the period 2004–2006 with a diagnosis of anterior IS. Demographic, clinical and hematological information was collected. Uni- and multivariate logistic regression analyses were used to estimate risk for spontaneous HT. Results: We included 240 patients (125 males, 52%), mean age at admission was 72.5 years. HT was observed in 29 patients (12%). At univariate analysis, consciousness impairment at admission (OR 5.6, 95% CI 1.3–28.2), the presence of early CT signs (OR 2.4, 95% CI 1.1–5.3), infarcts of medium-large size (OR 11.3, 95% CI 4.1–30.8), cardioembolic stroke (OR 2.3, 95% CI 1.1–5.2) and low total cholesterol levels (OR 3.3, 95% CI 1.3–8.2) were significantly associated with HT. At multivariate analysis, only infarct size (OR 10.2, 95% CI 3.2–32.1) was still significantly associated with HT. Conclusions: Frequency of HT in our study was 12%. Consistently with previous results, HT was associated with the size of ischemic area. As patients included in our study did not receive thrombolytic therapy, our results are applicable to those patients whom clinicians, working in a hospital setting, usually deal with.

1 August 2022 in Stroke
Verified
Journal Article
Closed access
PDF file
MPMaurizio Paciaroni
Maurizio Paciaroni
VCValeria Caso
Valeria Caso
GAGiancarlo Agnelli
Giancarlo Agnelli
MMMaria Giulia Mosconi
Maria Giulia Mosconi
MGMichela Giustozzi
Michela Giustozzi
GMGian Marco De Marchis
Gian Marco De Marchis
Background: In patients with atrial fibrillation who suffered an ischemic stroke while on treatment with nonvitamin K antagonist oral anticoagulants, rates and determinants of recurrent ischemic events and major bleedings remain uncertain. Methods: This prospective multicenter observational study aimed to estimate the rates of ischemic and bleeding events and their determinants in the follow-up of consecutive patients with atrial fibrillation who suffered an acute cerebrovascular ischemic event while on nonvitamin K antagonist oral anticoagulant treatment. Afterwards, we compared the estimated risks of ischemic and bleeding events between the patients in whom anticoagulant therapy was changed to those who continued the original treatment. Results: After a mean follow-up time of 15.0±10.9 months, 192 out of 1240 patients (15.5%) had 207 ischemic or bleeding events corresponding to an annual rate of 13.4%. Among the events, 111 were ischemic strokes, 15 systemic embolisms, 24 intracranial bleedings, and 57 major extracranial bleedings. Predictive factors of recurrent ischemic events (strokes and systemic embolisms) included CHA 2 DS 2 -VASc score after the index event (odds ratio [OR], 1.2 [95% CI, 1.0–1.3] for each point increase; P =0.05) and hypertension (OR, 2.3 [95% CI, 1.0–5.1]; P =0.04). Predictive factors of bleeding events (intracranial and major extracranial bleedings) included age (OR, 1.1 [95% CI, 1.0–1.2] for each year increase; P =0.002), history of major bleeding (OR, 6.9 [95% CI, 3.4–14.2]; P =0.0001) and the concomitant administration of an antiplatelet agent (OR, 2.8 [95% CI, 1.4–5.5]; P =0.003). Rates of ischemic and bleeding events were no different in patients who changed or not changed the original nonvitamin K antagonist oral anticoagulants treatment (OR, 1.2 [95% CI, 0.8–1.7]). Conclusions: Patients suffering a stroke despite being on nonvitamin K antagonist oral anticoagulant therapy are at high risk of recurrent ischemic stroke and bleeding. In these patients, further research is needed to improve secondary prevention by investigating the mechanisms of recurrent ischemic stroke and bleeding.

12 September 2016 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
FSFabrizio Sallustio
Fabrizio Sallustio
CMCaterina Motta
Caterina Motta
SPSilvia Pizzuto
Silvia Pizzuto
MDMarina Diomedi
Marina Diomedi
AGAngela Giordano
Angela Giordano
GKgiacomo koch
giacomo koch
Background Collateral flow (CF) is an effective predictor of outcome in acute ischemic stroke (AIS) with potential to sustain the ischemic penumbra. However, the clinical prognostic value of CF in patients with AIS undergoing mechanical thrombectomy has not been clearly established. We evaluated the relationship of CF with clinical outcomes in patients with large artery anterior circulation AIS treated with mechanical thrombectomy. Methods Baseline collaterals of patients with AIS (n=135) undergoing mechanical thrombectomy were independently evaluated by CT angiography (CTA) and conventional angiography and dichotomized into poor and good CF. Multivariable analyses were performed to evaluate the predictive effect of CF on outcome and the effect of time to reperfusion on outcome based on adequacy of the collaterals. Results Evaluation of CF was consistent by both CTA and conventional angiography (p<0.0001). A higher rate of patients with good collaterals had good functional outcome at 3-month follow-up compared with those with poor collaterals (modified Rankin Scale (mRS) 0–2: 60% vs 10%, p=0.0001). Patients with poor collaterals had a significantly higher mortality rate (mRS 6: 45% vs 8%, p=0.0001). Multivariable analyses showed that CF was the strongest predictor of outcome. Time to reperfusion had a clear effect on favorable outcome (mRS ≤2) in patients with good collaterals; in patients with poor collaterals this effect was only seen when mRS ≤3 was considered an acceptable outcome. Conclusions CTA is a valid tool for assessing the ability of CF to predict clinical outcome in patients with AIS treated with mechanical thrombectomy. Limiting time to reperfusion is of definite value in patients with good collaterals and also to some extent in those with poor collaterals.

30 May 2009 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
Giuseppe SalemiGiuseppe Salemi
Giuseppe Salemi
MGM. C. Gueli
M. C. Gueli
MDM. D’aMelio
M. D’aMelio
VSV. Saia
V. Saia
PMP. Mangiapane
P. Mangiapane
ILI. Lupo
I. Lupo